MicroRNA Related Polymorphisms and Breast Cancer Risk

• Sofia Khan,

  Affiliation Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland

  ⨯
• Dario Greco,

  Affiliations Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland, Finnish Institute of Occupational Health, Helsinki, Finland

  ⨯
• Kyriaki Michailidou,

  Affiliation Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Roger L. Milne,

  Affiliations Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia

  ⨯
• Taru A. Muranen,

  Affiliation Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland

  ⨯
• Tuomas Heikkinen,

  Affiliation Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland

  ⨯
• Kirsimari Aaltonen,

  Affiliations Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland, Department of Clinical Genetics, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland, Department of Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland

  ⨯
• Joe Dennis,

  Affiliation Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Manjeet K. Bolla,

  Affiliation Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Jianjun Liu,

  Affiliation Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore

  ⨯
• Per Hall,

  Affiliation Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Astrid Irwanto,

  Affiliation Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore

  ⨯
• Keith Humphreys,

  Affiliation Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Jingmei Li,

  Affiliation Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore

  ⨯
• Kamila Czene,

  Affiliation Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Jenny Chang-Claude,

  Affiliation Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany

  ⨯
• Rebecca Hein,

  Affiliations Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany, PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany

  ⨯
• Anja Rudolph,

  Affiliation Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany

  ⨯
• Petra Seibold,

  Affiliation Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany

  ⨯
• Dieter Flesch-Janys,

  Affiliation Department of Cancer Epidemiology/Clinical Cancer Registry and Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg, Germany

  ⨯
• Olivia Fletcher,

  Affiliation Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom

  ⨯
• Julian Peto,

  Affiliation Department of Non-Communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine, London, United Kingdom

  ⨯
• Isabel dos Santos Silva,

  Affiliation Department of Non-Communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine, London, United Kingdom

  ⨯
• Nichola Johnson,

  Affiliation Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom

  ⨯
• Lorna Gibson,

  Affiliation Department of Non-Communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine, London, United Kingdom

  ⨯
• Zoe Aitken,

  Affiliation Department of Non-Communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine, London, United Kingdom

  ⨯
• John L. Hopper,

  Affiliation Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia

  ⨯
• Helen Tsimiklis,

  Affiliation Department of Pathology, The University of Melbourne, Melbourne, Australia

  ⨯
• Minh Bui,

  Affiliation Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia

  ⨯
• Enes Makalic,

  Affiliation Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia

  ⨯
• Daniel F. Schmidt,

  Affiliation Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia

  ⨯
• Melissa C. Southey,

  Affiliation Department of Pathology, The University of Melbourne, Melbourne, Australia

  ⨯
• Carmel Apicella,

  Affiliation Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia

  ⨯
• Jennifer Stone,

  Affiliation Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia

  ⨯
• Quinten Waisfisz,

  Affiliation Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands

  ⨯
• Hanne Meijers-Heijboer,

  Affiliation Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands

  ⨯
• Muriel A. Adank,

  Affiliation Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands

  ⨯
• Rob B. van der Luijt,

  Affiliation Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands

  ⨯
• Alfons Meindl,

  Affiliation Division of Gynaecology and Obstetrics, Technische Universität München, Munich, Germany

  ⨯
• Rita K. Schmutzler,

  Affiliations Division of Molecular Gyneco-Oncology, Department of Gynaecology and Obstetrics, University Hospital of Cologne, Cologne, Germany, Center of Familial Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany, Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany, Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany

  ⨯
• Bertram Müller-Myhsok,

  Affiliation Max Planck Institute of Psychiatry, Munich, Germany

  ⨯
• Peter Lichtner,

  Affiliation Institute of Human Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany

  ⨯
• Clare Turnbull,

  Affiliation Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom

  ⨯
• Nazneen Rahman,

  Affiliation Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom

  ⨯
• Stephen J. Chanock,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America

  ⨯
• David J. Hunter,

  Affiliations Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America, Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America

  ⨯
• Angela Cox,

  Affiliation CRUK/YCR Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Sheffield, United Kingdom

  ⨯
• Simon S. Cross,

  Affiliation Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, United Kingdom

  ⨯
• Malcolm W. R. Reed,

  Affiliation CRUK/YCR Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Sheffield, United Kingdom

  ⨯
• Marjanka K. Schmidt,

  Affiliation Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands

  ⨯
• Annegien Broeks,

  Affiliation Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands

  ⨯
• Laura J. V. a. n't. Veer,

  Affiliation Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands

  ⨯
• Frans B. Hogervorst,

  Affiliation Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands

  ⨯
• Peter A. Fasching,

  Affiliations University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Cancer Erlangen-EMN, Erlangen, Germany, David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California Los Angeles, California, United States of America

  ⨯
• Michael G. Schrauder,

  Affiliation University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Cancer Erlangen-EMN, Erlangen, Germany

  ⨯
• Arif B. Ekici,

  Affiliation Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany

  ⨯
• Matthias W. Beckmann,

  Affiliation University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Cancer Erlangen-EMN, Erlangen, Germany

  ⨯
• Stig E. Bojesen,

  Affiliations Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark, Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark

  ⨯
• Børge G. Nordestgaard,

  Affiliations Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark, Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark

  ⨯
• Sune F. Nielsen,

  Affiliations Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark, Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark

  ⨯
• Henrik Flyger,

  Affiliation Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark

  ⨯
• Javier Benitez,

  Affiliations Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain, Centro de Investigación en Red de Enfermedades Raras (CIBERER), Valencia, Spain

  ⨯
• Pilar M. Zamora,

  Affiliation Servicio de Oncología Médica, Hospital Universitario La Paz, Madrid, Spain

  ⨯
• Jose I. A. Perez,

  Affiliation Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, Oviedo, Spain

  ⨯
• Christopher A. Haiman,

  Affiliation Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America

  ⨯
• Brian E. Henderson,

  Affiliation Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America

  ⨯
• Fredrick Schumacher,

  Affiliation Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America

  ⨯
• Loic Le Marchand,

  Affiliation Epidemiology Program, Cancer Research Center, University of Hawaii, Honolulu, Hawaii, United States of America

  ⨯
• Paul D. P. Pharoah,

  Affiliations Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom, Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Alison M. Dunning,

  Affiliation Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Mitul Shah,

  Affiliation Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Robert Luben,

  Affiliation Clinical Gerontology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Judith Brown,

  Affiliation Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Fergus J. Couch,

  Affiliation Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Xianshu Wang,

  Affiliation Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Celine Vachon,

  Affiliation Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Janet E. Olson,

  Affiliation Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Diether Lambrechts,

  Affiliations Vesalius Research Center (VRC), VIB, Leuven, Belgium, Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium

  ⨯
• Matthieu Moisse,

  Affiliations Vesalius Research Center (VRC), VIB, Leuven, Belgium, Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium

  ⨯
• Robert Paridaens,

  Affiliation Oncology Department, University Hospital Gasthuisberg, Leuven, Belgium

  ⨯
• Marie-Rose Christiaens,

  Affiliation Oncology Department, University Hospital Gasthuisberg, Leuven, Belgium

  ⨯
• Pascal Guénel,

  Affiliations Inserm (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, Villejuif, France, University Paris-Sud, UMRS 1018, Villejuif, France

  ⨯
• Thérèse Truong,

  Affiliations Inserm (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, Villejuif, France, University Paris-Sud, UMRS 1018, Villejuif, France

  ⨯
• Pierre Laurent-Puig,

  Affiliation Université Paris Sorbonne Cité, UMR-S775 Inserm, Paris, France

  ⨯
• Claire Mulot,

  Affiliation Université Paris Sorbonne Cité, UMR-S775 Inserm, Paris, France

  ⨯
• Frederick Marme,

  Affiliations Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany, National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany

  ⨯
• Barbara Burwinkel,

  Affiliations Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany, Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany

  ⨯
• Andreas Schneeweiss,

  Affiliations Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany, National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany

  ⨯
• Christof Sohn,

  Affiliation Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany

  ⨯
• Elinor J. Sawyer,

  Affiliation Research Oncology, Division of Cancer Studies, King's College London, Guy's Hospital, London, United Kingdom

  ⨯
• Ian Tomlinson,

  Affiliation Wellcome Trust Centre for Human Genetics and Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom

  ⨯
• Michael J. Kerin,

  Affiliation Clinical Science Institute, University Hospital Galway, Galway, Ireland

  ⨯
• Nicola Miller,

  Affiliation Clinical Science Institute, University Hospital Galway, Galway, Ireland

  ⨯
• Irene L. Andrulis,

  Affiliations Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada, Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada

  ⨯
• Julia A. Knight,

  Affiliations Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada, Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada

  ⨯
• Sandrine Tchatchou,

  Affiliation Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada

  ⨯
• Anna Marie Mulligan,

  Affiliations Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada, Department of Laboratory Medicine, and the Keenan Research Centre of the Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, Ontario, Canada

  ⨯
• Thilo Dörk,

  Affiliation Department of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany

  ⨯
• Natalia V. Bogdanova,

  Affiliation Department of Radiation Oncology, Hannover Medical School, Hannover, Germany

  ⨯
• Natalia N. Antonenkova,

  Affiliation N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus

  ⨯
• Hoda Anton-Culver,

  Affiliation Department of Epidemiology, University of California Irvine, Irvine, California, United States of America

  ⨯
• Hatef Darabi,

  Affiliation Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Mikael Eriksson,

  Affiliation Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Montserrat Garcia-Closas,

  Affiliations Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, United Kingdom, Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London, United Kingdom

  ⨯
• Jonine Figueroa,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America

  ⨯
• Jolanta Lissowska,

  Affiliation Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland

  ⨯
• Louise Brinton,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America

  ⨯
• Peter Devilee,

  Affiliation Department of Human Genetics & Department of Pathology, Leiden University Medical Center, Leiden, Netherlands

  ⨯
• Robert A. E. M. Tollenaar,

  Affiliation Department of Surgical Oncology, Leiden University Medical Center, Leiden, Netherlands

  ⨯
• Caroline Seynaeve,

  Affiliation Family Cancer Clinic, Department of Medical Oncology, Erasmus MC-Daniel den Hoed Cancer Center, Rotterdam, Netherlands

  ⨯
• Christi J. van Asperen,

  Affiliation Department of Clinical Genetics, Leiden University Medical Center, Leiden, Netherlands

  ⨯
• Vessela N. Kristensen,

  Affiliations Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway, Department of Clinical Molecular Biology (EpiGen), University of Oslo, Oslo, Norway, Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo, Norway

  ⨯
• kConFab Investigators ,

  ¶Membership of the GENICA Network, kConFab Investigators, and AOCS is provided in the Acknowledgments.

  Affiliation Peter MacCallum Cancer Center, Melbourne, Australia

  ⨯
• Australian Ovarian Cancer Study Group ,

  ¶Membership of the GENICA Network, kConFab Investigators, and AOCS is provided in the Acknowledgments.

  Affiliations Peter MacCallum Cancer Center, Melbourne, Australia, QIMR Berghofer Medical Research Institute, Brisbane, Australia

  ⨯
• Susan Slager,

  Affiliation Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Amanda E. Toland,

  Affiliation Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America

  ⨯
• Christine B. Ambrosone,

  Affiliation Roswell Park Cancer Institute, Buffalo, New York, United States of America

  ⨯
• Drakoulis Yannoukakos,

  Affiliation Molecular Diagnostics Laboratory, IRRP, National Centre for Scientific Research "Demokritos", Aghia Paraskevi Attikis, Athens, Greece

  ⨯
• Annika Lindblom,

  Affiliation Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Sara Margolin,

  Affiliation Department of Oncology - Pathology, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Paolo Radice,

  Affiliation Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy

  ⨯
• Paolo Peterlongo,

  Affiliation IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy

  ⨯
• Monica Barile,

  Affiliation Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia (IEO), Milan, Italy

  ⨯
• Paolo Mariani,

  Affiliations IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy, Cogentech Cancer Genetic Test Laboratory, Milan, Italy

  ⨯
• Maartje J. Hooning,

  Affiliation Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands

  ⨯
• John W. M. Martens,

  Affiliation Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands

  ⨯
• J. Margriet Collée,

  Affiliation Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands

  ⨯
• Agnes Jager,

  Affiliation Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands

  ⨯
• Anna Jakubowska,

  Affiliation Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland

  ⨯
• Jan Lubinski,

  Affiliation Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland

  ⨯
• Katarzyna Jaworska-Bieniek,

  Affiliations Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland, Postgraduate School of Molecular Medicine, Warsaw Medical University, Warsaw, Poland

  ⨯
• Katarzyna Durda,

  Affiliation Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland

  ⨯
• Graham G. Giles,

  Affiliations Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia

  ⨯
• Catriona McLean,

  Affiliation Anatomical Pathology, The Alfred Hospital, Melbourne, Australia

  ⨯
• Hiltrud Brauch,

  Affiliations Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany, University of Tübingen, Tübingen, Germany

  ⨯
• Thomas Brüning,

  Affiliation Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-University Bochum (IPA), Bochum, Germany

  ⨯
• Yon-Dschun Ko,

  Affiliation Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany

  ⨯
• The GENICA Network ,

  ¶Membership of the GENICA Network, kConFab Investigators, and AOCS is provided in the Acknowledgments.

  Affiliations Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany, University of Tübingen, Tübingen, Germany, Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-University Bochum (IPA), Bochum, Germany, Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany, Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany, Institute for Occupational Medicine and Maritime Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, Institute of Pathology, Medical Faculty of the University of Bonn, Bonn, Germany

  ⨯
• Hermann Brenner,

  Affiliations Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany, German Cancer Consortium (DKTK), Heidelberg, Germany

  ⨯
• Aida Karina Dieffenbach,

  Affiliations Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany, German Cancer Consortium (DKTK), Heidelberg, Germany

  ⨯
• Volker Arndt,

  Affiliation Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany

  ⨯
• Christa Stegmaier,

  Affiliation Saarland Cancer Registry, Saarbrücken, Germany

  ⨯
• Anthony Swerdlow,

  Affiliation Division of Genetics and Epidemiology and Division of Breast Cancer Research, The Institute of Cancer Research, Sutton, Surrey, United Kingdom

  ⨯
• Alan Ashworth,

  Affiliation Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom

  ⨯
• Nick Orr,

  Affiliation Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom

  ⨯
• Michael Jones,

  Affiliation Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, United Kingdom

  ⨯
• Jacques Simard,

  Affiliation Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec, Canada

  ⨯
• Mark S. Goldberg,

  Affiliations Department of Medicine, McGill University, Montreal, Canada, Division of Clinical Epidemiology, McGill University Health Centre, Royal Victoria Hospital, Montreal, Quebec, Canada

  ⨯
• France Labrèche,

  Affiliation Départements de Santé Environnementale et Santé au Travail et de Médecine Sociale et Préventive, Université de Montréal, Montreal, Quebec, Canada

  ⨯
• Martine Dumont,

  Affiliation Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec, Canada

  ⨯
• Robert Winqvist,

  Affiliation Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry and Biocenter Oulu, University of Oulu, NordLab Oulu/Oulu University Hospital, Oulu, Finland

  ⨯
• Katri Pylkäs,

  Affiliation Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry and Biocenter Oulu, University of Oulu, NordLab Oulu/Oulu University Hospital, Oulu, Finland

  ⨯
• Arja Jukkola-Vuorinen,

  Affiliation Department of Oncology, Oulu University Hospital, University of Oulu, Oulu, Finland

  ⨯
• Mervi Grip,

  Affiliation Department of Surgery, Oulu University Hospital, University of Oulu, Oulu, Finland

  ⨯
• Vesa Kataja,

  Affiliations School of Medicine, Institute of Clinical Medicine, Oncology, University of Eastern Finland, Kuopio, Finland, Cancer Center, Kuopio University Hospital, Kuopio, Finland

  ⨯
• Veli-Matti Kosma,

  Affiliations School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland, Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland, Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland

  ⨯
• Jaana M. Hartikainen,

  Affiliations School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland, Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland, Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland

  ⨯
• Arto Mannermaa,

  Affiliations School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland, Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland, Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland

  ⨯
• Ute Hamann,

  Affiliation Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany

  ⨯
• Georgia Chenevix-Trench,

  Affiliation Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia

  ⨯
• Carl Blomqvist,

  Affiliation Department of Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland

  ⨯
• Kristiina Aittomäki,

  Affiliation Department of Clinical Genetics, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland

  ⨯
• Douglas F. Easton,

  Affiliations Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom, Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom

  ⨯
•  [ ... ],
• Heli Nevanlinna

  * E-mail: heli.nevanlinna@hus.fi

  Affiliation Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland

  ⨯
• [ view all ]
• [ view less ]